APO Research
Talk to an analyst

APO RESEARCH · REPORT

TYK2 Targeting Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global TYK2 Targeting Drugs Market Analysis and Forecast 2026-2032

29 December 2025198 pages

Choose your research edition.

Industry ResearchTYK2 Targeting Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal TYK2 Targeting Drugs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal TYK2 Targeting Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TYK2 Targeting Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal TYK2 Targeting Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global TYK2 Targeting Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for TYK2 Targeting Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for TYK2 Targeting Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for TYK2 Targeting Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for TYK2 Targeting Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of TYK2 Targeting Drugs include Inventisbio, Qiyuan Biotechnology, InnoCare, Guangzhou Zaiji Pharmaceutical, Changzhou Hengbang Pharmaceutical, BeiGene, Ventyx Biosciences, Takeda (Nimbus Therapeutics) and Sareum Holdings Pic, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for TYK2 Targeting Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of TYK2 Targeting Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for TYK2 Targeting Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the TYK2 Targeting Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global TYK2 Targeting Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for TYK2 Targeting Drugs sales, projected growth trends, production technology, application and end-user industry.

TYK2 Targeting Drugs Segment by Company

Inventisbio

Qiyuan Biotechnology

InnoCare

Guangzhou Zaiji Pharmaceutical

Changzhou Hengbang Pharmaceutical

BeiGene

Ventyx Biosciences

Takeda (Nimbus Therapeutics)

Sareum Holdings Pic

Oncostellae

Galapagos NV

Bristol Myers Squibb

TYK2 Targeting Drugs Segment by Type

Single-target Inhibitors

Dual-target Inhibitors

TYK2 Targeting Drugs Segment by Application

Psoriasis

Systemic Lupus Erythematosus

Dermatitis

Arthritis

Others

TYK2 Targeting Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TYK2 Targeting Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TYK2 Targeting Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TYK2 Targeting Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of TYK2 Targeting Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of TYK2 Targeting Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, TYK2 Targeting Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global TYK2 Targeting Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single-target Inhibitors Major Manufacturers Table 3. Dual-target Inhibitors Major Manufacturers Table 4. Global TYK2 Targeting Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Psoriasis Major Manufacturers Table 6. Systemic Lupus Erythematosus Major Manufacturers Table 7. Dermatitis Major Manufacturers Table 8. Arthritis Major Manufacturers Table 9. Others Major Manufacturers Table 10. TYK2 Targeting Drugs Industry Trends Table 11. TYK2 Targeting Drugs Industry Drivers Table 12. TYK2 Targeting Drugs Industry Opportunities and Challenges Table 13. TYK2 Targeting Drugs Industry Restraints Table 14. Global TYK2 Targeting Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global TYK2 Targeting Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global TYK2 Targeting Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global TYK2 Targeting Drugs Revenue Market Share by Region (2021-2026) Table 18. Global TYK2 Targeting Drugs Revenue Market Share by Region (2027-2032) Table 19. Global TYK2 Targeting Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global TYK2 Targeting Drugs Sales by Region (2021-2026) & (K Units) Table 21. Global TYK2 Targeting Drugs Sales by Region (2027-2032) & (K Units) Table 22. Global TYK2 Targeting Drugs Sales Market Share by Region (2021-2026) Table 23. Global TYK2 Targeting Drugs Sales Market Share by Region (2027-2032) Table 24. Global TYK2 Targeting Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global TYK2 Targeting Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global TYK2 Targeting Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global TYK2 Targeting Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global TYK2 Targeting Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global TYK2 Targeting Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global TYK2 Targeting Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global TYK2 Targeting Drugs Manufacturers, Product Type & Application Table 32. Global TYK2 Targeting Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global TYK2 Targeting Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global TYK2 Targeting Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global TYK2 Targeting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global TYK2 Targeting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global TYK2 Targeting Drugs Revenue Market Share by Type (2021-2026) Table 39. Global TYK2 Targeting Drugs Revenue Market Share by Type (2027-2032) Table 40. Global TYK2 Targeting Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 42. Global TYK2 Targeting Drugs Sales by Type (2027-2032) & (K Units) Table 43. Global TYK2 Targeting Drugs Sales Market Share by Type (2021-2026) Table 44. Global TYK2 Targeting Drugs Sales Market Share by Type (2027-2032) Table 45. Global TYK2 Targeting Drugs Price by Type (2021-2026) & (US$/Unit) Table 46. Global TYK2 Targeting Drugs Price by Type (2027-2032) & (US$/Unit) Table 47. Global TYK2 Targeting Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global TYK2 Targeting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global TYK2 Targeting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global TYK2 Targeting Drugs Revenue Market Share by Application (2021-2026) Table 51. Global TYK2 Targeting Drugs Revenue Market Share by Application (2027-2032) Table 52. Global TYK2 Targeting Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global TYK2 Targeting Drugs Sales by Application (2027-2032) & (K Units) Table 55. Global TYK2 Targeting Drugs Sales Market Share by Application (2021-2026) Table 56. Global TYK2 Targeting Drugs Sales Market Share by Application (2027-2032) Table 57. Global TYK2 Targeting Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global TYK2 Targeting Drugs Price by Application (2027-2032) & (US$/Unit) Table 59. Inventisbio Company Information Table 60. Inventisbio Business Overview Table 61. Inventisbio TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Inventisbio TYK2 Targeting Drugs Product Portfolio Table 63. Inventisbio Recent Development Table 64. Qiyuan Biotechnology Company Information Table 65. Qiyuan Biotechnology Business Overview Table 66. Qiyuan Biotechnology TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Qiyuan Biotechnology TYK2 Targeting Drugs Product Portfolio Table 68. Qiyuan Biotechnology Recent Development Table 69. InnoCare Company Information Table 70. InnoCare Business Overview Table 71. InnoCare TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. InnoCare TYK2 Targeting Drugs Product Portfolio Table 73. InnoCare Recent Development Table 74. Guangzhou Zaiji Pharmaceutical Company Information Table 75. Guangzhou Zaiji Pharmaceutical Business Overview Table 76. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product Portfolio Table 78. Guangzhou Zaiji Pharmaceutical Recent Development Table 79. Changzhou Hengbang Pharmaceutical Company Information Table 80. Changzhou Hengbang Pharmaceutical Business Overview Table 81. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product Portfolio Table 83. Changzhou Hengbang Pharmaceutical Recent Development Table 84. BeiGene Company Information Table 85. BeiGene Business Overview Table 86. BeiGene TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. BeiGene TYK2 Targeting Drugs Product Portfolio Table 88. BeiGene Recent Development Table 89. Ventyx Biosciences Company Information Table 90. Ventyx Biosciences Business Overview Table 91. Ventyx Biosciences TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Ventyx Biosciences TYK2 Targeting Drugs Product Portfolio Table 93. Ventyx Biosciences Recent Development Table 94. Takeda (Nimbus Therapeutics) Company Information Table 95. Takeda (Nimbus Therapeutics) Business Overview Table 96. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product Portfolio Table 98. Takeda (Nimbus Therapeutics) Recent Development Table 99. Sareum Holdings Pic Company Information Table 100. Sareum Holdings Pic Business Overview Table 101. Sareum Holdings Pic TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Sareum Holdings Pic TYK2 Targeting Drugs Product Portfolio Table 103. Sareum Holdings Pic Recent Development Table 104. Oncostellae Company Information Table 105. Oncostellae Business Overview Table 106. Oncostellae TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Oncostellae TYK2 Targeting Drugs Product Portfolio Table 108. Oncostellae Recent Development Table 109. Galapagos NV Company Information Table 110. Galapagos NV Business Overview Table 111. Galapagos NV TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Galapagos NV TYK2 Targeting Drugs Product Portfolio Table 113. Galapagos NV Recent Development Table 114. Bristol Myers Squibb Company Information Table 115. Bristol Myers Squibb Business Overview Table 116. Bristol Myers Squibb TYK2 Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Bristol Myers Squibb TYK2 Targeting Drugs Product Portfolio Table 118. Bristol Myers Squibb Recent Development Table 119. North America TYK2 Targeting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 120. North America TYK2 Targeting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 121. North America TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 122. North America TYK2 Targeting Drugs Sales by Type (2027-2032) & (K Units) Table 123. North America TYK2 Targeting Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 124. North America TYK2 Targeting Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 125. North America TYK2 Targeting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 126. North America TYK2 Targeting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 127. North America TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 128. North America TYK2 Targeting Drugs Sales by Application (2027-2032) & (K Units) Table 129. North America TYK2 Targeting Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 130. North America TYK2 Targeting Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 131. North America TYK2 Targeting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America TYK2 Targeting Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. North America TYK2 Targeting Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. North America TYK2 Targeting Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 135. North America TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 136. North America TYK2 Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 137. North America TYK2 Targeting Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 138. North America TYK2 Targeting Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 139. United States TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 140. Canada TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 141. Mexico TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 142. Europe TYK2 Targeting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 143. Europe TYK2 Targeting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 144. Europe TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 145. Europe TYK2 Targeting Drugs Sales by Type (2027-2032) & (K Units) Table 146. Europe TYK2 Targeting Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 147. Europe TYK2 Targeting Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 148. Europe TYK2 Targeting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 149. Europe TYK2 Targeting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 150. Europe TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 151. Europe TYK2 Targeting Drugs Sales by Application (2027-2032) & (K Units) Table 152. Europe TYK2 Targeting Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 153. Europe TYK2 Targeting Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 154. Europe TYK2 Targeting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Europe TYK2 Targeting Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Europe TYK2 Targeting Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Europe TYK2 Targeting Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 158. Europe TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 159. Europe TYK2 Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 160. Europe TYK2 Targeting Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 161. Europe TYK2 Targeting Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 162. Germany TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 163. France TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 164. U.K. TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 165. Italy TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 166. Russia TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 167. Spain TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 168. Netherlands TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 169. Switzerland TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 170. Sweden TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 171. Poland TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 172. China TYK2 Targeting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 173. China TYK2 Targeting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 174. China TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 175. China TYK2 Targeting Drugs Sales by Type (2027-2032) & (K Units) Table 176. China TYK2 Targeting Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 177. China TYK2 Targeting Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 178. China TYK2 Targeting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 179. China TYK2 Targeting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 180. China TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 181. China TYK2 Targeting Drugs Sales by Application (2027-2032) & (K Units) Table 182. China TYK2 Targeting Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 183. China TYK2 Targeting Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Asia TYK2 Targeting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 185. Asia TYK2 Targeting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 186. Asia TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 187. Asia TYK2 Targeting Drugs Sales by Type (2027-2032) & (K Units) Table 188. Asia TYK2 Targeting Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 189. Asia TYK2 Targeting Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 190. Asia TYK2 Targeting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 191. Asia TYK2 Targeting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 192. Asia TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 193. Asia TYK2 Targeting Drugs Sales by Application (2027-2032) & (K Units) Table 194. Asia TYK2 Targeting Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 195. Asia TYK2 Targeting Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 196. Asia TYK2 Targeting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. Asia TYK2 Targeting Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. Asia TYK2 Targeting Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. Asia TYK2 Targeting Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 200. Asia TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 201. Asia TYK2 Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 202. Asia TYK2 Targeting Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 203. Asia TYK2 Targeting Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 204. Japan TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 205. South Korea TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 206. India TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 207. Australia TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 208. Taiwan TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 209. Southeast Asia TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 210. SAMEA TYK2 Targeting Drugs Revenue by Type (2021-2026) & (US$ Million) Table 211. SAMEA TYK2 Targeting Drugs Revenue by Type (2027-2032) & (US$ Million) Table 212. SAMEA TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 213. SAMEA TYK2 Targeting Drugs Sales by Type (2027-2032) & (K Units) Table 214. SAMEA TYK2 Targeting Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 215. SAMEA TYK2 Targeting Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 216. SAMEA TYK2 Targeting Drugs Revenue by Application (2021-2026) & (US$ Million) Table 217. SAMEA TYK2 Targeting Drugs Revenue by Application (2027-2032) & (US$ Million) Table 218. SAMEA TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 219. SAMEA TYK2 Targeting Drugs Sales by Application (2027-2032) & (K Units) Table 220. SAMEA TYK2 Targeting Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 221. SAMEA TYK2 Targeting Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 222. SAMEA TYK2 Targeting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 223. SAMEA TYK2 Targeting Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 224. SAMEA TYK2 Targeting Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 225. SAMEA TYK2 Targeting Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 226. SAMEA TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 227. SAMEA TYK2 Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 228. SAMEA TYK2 Targeting Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 229. SAMEA TYK2 Targeting Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 230. Brazil TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 231. Argentina TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 232. Chile TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 233. Colombia TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 234. Peru TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 235. Saudi Arabia TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 236. Israel TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 237. UAE TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 238. Turkey TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 239. Iran TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 240. Egypt TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Table 241. Key Raw Materials Table 242. Raw Materials Key Suppliers Table 243. TYK2 Targeting Drugs Distributors List Table 244. TYK2 Targeting Drugs Customers List Table 245. Research Programs/Design for This Report Table 246. Authors List of This Report Table 247. Secondary Sources Table 248. Primary Sources List of Figures Figure 1. TYK2 Targeting Drugs Image Figure 2. Global TYK2 Targeting Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TYK2 Targeting Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single-target Inhibitors Image Figure 5. Dual-target Inhibitors Image Figure 6. Global TYK2 Targeting Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global TYK2 Targeting Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Psoriasis Image Figure 9. Systemic Lupus Erythematosus Image Figure 10. Dermatitis Image Figure 11. Arthritis Image Figure 12. Others Image Figure 13. Global TYK2 Targeting Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global TYK2 Targeting Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global TYK2 Targeting Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global TYK2 Targeting Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global TYK2 Targeting Drugs Sales (2021-2032) & (K Units) Figure 19. Global TYK2 Targeting Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global TYK2 Targeting Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico TYK2 Targeting Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Europe TYK2 Targeting Drugs Sales YoY (2021-2032) & (K Units) Figure 23. China TYK2 Targeting Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) TYK2 Targeting Drugs Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa TYK2 Targeting Drugs Sales YoY (2021-2032) & (K Units) Figure 26. Global TYK2 Targeting Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global TYK2 Targeting Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global TYK2 Targeting Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global TYK2 Targeting Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global TYK2 Targeting Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global TYK2 Targeting Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global TYK2 Targeting Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global TYK2 Targeting Drugs Sales Market Share by Type (2021-2032) Figure 35. Global TYK2 Targeting Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global TYK2 Targeting Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global TYK2 Targeting Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global TYK2 Targeting Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global TYK2 Targeting Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global TYK2 Targeting Drugs Sales Market Share by Application (2021-2032) Figure 41. North America TYK2 Targeting Drugs Revenue Share by Type (2021-2032) Figure 42. North America TYK2 Targeting Drugs Sales Share by Type (2021-2032) Figure 43. North America TYK2 Targeting Drugs Revenue Share by Application (2021-2032) Figure 44. North America TYK2 Targeting Drugs Sales Share by Application (2021-2032) Figure 45. North America TYK2 Targeting Drugs Revenue Share by Country (2021-2032) Figure 46. North America TYK2 Targeting Drugs Sales Share by Country (2021-2032) Figure 47. Europe TYK2 Targeting Drugs Revenue Share by Type (2021-2032) Figure 48. Europe TYK2 Targeting Drugs Sales Share by Type (2021-2032) Figure 49. Europe TYK2 Targeting Drugs Revenue Share by Application (2021-2032) Figure 50. Europe TYK2 Targeting Drugs Sales Share by Application (2021-2032) Figure 51. Europe TYK2 Targeting Drugs Revenue Share by Country (2021-2032) Figure 52. Europe TYK2 Targeting Drugs Sales Share by Country (2021-2032) Figure 53. China TYK2 Targeting Drugs Revenue Share by Type (2021-2032) Figure 54. China TYK2 Targeting Drugs Sales Share by Type (2021-2032) Figure 55. China TYK2 Targeting Drugs Revenue Share by Application (2021-2032) Figure 56. China TYK2 Targeting Drugs Sales Share by Application (2021-2032) Figure 57. Asia TYK2 Targeting Drugs Revenue Share by Type (2021-2032) Figure 58. Asia TYK2 Targeting Drugs Sales Share by Type (2021-2032) Figure 59. Asia TYK2 Targeting Drugs Revenue Share by Application (2021-2032) Figure 60. Asia TYK2 Targeting Drugs Sales Share by Application (2021-2032) Figure 61. Asia TYK2 Targeting Drugs Revenue Share by Country (2021-2032) Figure 62. Asia TYK2 Targeting Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA TYK2 Targeting Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA TYK2 Targeting Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA TYK2 Targeting Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA TYK2 Targeting Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA TYK2 Targeting Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA TYK2 Targeting Drugs Sales Share by Country (2021-2032) Figure 69. TYK2 Targeting Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. TYK2 Targeting Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Single-target Inhibitors
  • Dual-target Inhibitors
Applications
  • Psoriasis
  • Systemic Lupus Erythematosus
  • Dermatitis
  • Arthritis
  • Others
Companies covered
  • Inventisbio
  • Qiyuan Biotechnology
  • InnoCare
  • Guangzhou Zaiji Pharmaceutical
  • Changzhou Hengbang Pharmaceutical
  • BeiGene
  • Ventyx Biosciences
  • Takeda (Nimbus Therapeutics)
  • Sareum Holdings Pic
  • Oncostellae
  • Galapagos NV
  • Bristol Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 TYK2 Targeting Drugs Market by Type
  3. 1.2.1 Global TYK2 Targeting Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single-target Inhibitors
  5. 1.2.3 Dual-target Inhibitors
  6. 1.3 TYK2 Targeting Drugs Market by Application
  7. 1.3.1 Global TYK2 Targeting Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Psoriasis
  9. 1.3.3 Systemic Lupus Erythematosus
  10. 1.3.4 Dermatitis
  11. 1.3.5 Arthritis
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 TYK2 Targeting Drugs Market Dynamics
  1. 2.1 TYK2 Targeting Drugs Industry Trends
  2. 2.2 TYK2 Targeting Drugs Industry Drivers
  3. 2.3 TYK2 Targeting Drugs Industry Opportunities and Challenges
  4. 2.4 TYK2 Targeting Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global TYK2 Targeting Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global TYK2 Targeting Drugs Revenue by Region
  3. 3.2.1 Global TYK2 Targeting Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global TYK2 Targeting Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global TYK2 Targeting Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global TYK2 Targeting Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global TYK2 Targeting Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global TYK2 Targeting Drugs Sales by Region
  9. 3.4.1 Global TYK2 Targeting Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global TYK2 Targeting Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global TYK2 Targeting Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global TYK2 Targeting Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global TYK2 Targeting Drugs Revenue by Manufacturers
  2. 4.1.1 Global TYK2 Targeting Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global TYK2 Targeting Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global TYK2 Targeting Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global TYK2 Targeting Drugs Sales by Manufacturers
  6. 4.2.1 Global TYK2 Targeting Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global TYK2 Targeting Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global TYK2 Targeting Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global TYK2 Targeting Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global TYK2 Targeting Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global TYK2 Targeting Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global TYK2 Targeting Drugs Manufacturers, Product Type & Application
  13. 4.7 Global TYK2 Targeting Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global TYK2 Targeting Drugs Market CR5 and HHI
  16. 4.8.2 2025 TYK2 Targeting Drugs Tier 1, Tier 2, and Tier 3
5 TYK2 Targeting Drugs Market by Type
  1. 5.1 Global TYK2 Targeting Drugs Revenue by Type
  2. 5.1.1 Global TYK2 Targeting Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global TYK2 Targeting Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global TYK2 Targeting Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global TYK2 Targeting Drugs Sales by Type
  6. 5.2.1 Global TYK2 Targeting Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global TYK2 Targeting Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global TYK2 Targeting Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global TYK2 Targeting Drugs Price by Type
6 TYK2 Targeting Drugs Market by Application
  1. 6.1 Global TYK2 Targeting Drugs Revenue by Application
  2. 6.1.1 Global TYK2 Targeting Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global TYK2 Targeting Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global TYK2 Targeting Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global TYK2 Targeting Drugs Sales by Application
  6. 6.2.1 Global TYK2 Targeting Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global TYK2 Targeting Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global TYK2 Targeting Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global TYK2 Targeting Drugs Price by Application
7 Company Profiles
  1. 7.1 Inventisbio
  2. 7.1.1 Inventisbio Company Information
  3. 7.1.2 Inventisbio Business Overview
  4. 7.1.3 Inventisbio TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Inventisbio TYK2 Targeting Drugs Product Portfolio
  6. 7.1.5 Inventisbio Recent Developments
  7. 7.2 Qiyuan Biotechnology
  8. 7.2.1 Qiyuan Biotechnology Company Information
  9. 7.2.2 Qiyuan Biotechnology Business Overview
  10. 7.2.3 Qiyuan Biotechnology TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Qiyuan Biotechnology TYK2 Targeting Drugs Product Portfolio
  12. 7.2.5 Qiyuan Biotechnology Recent Developments
  13. 7.3 InnoCare
  14. 7.3.1 InnoCare Company Information
  15. 7.3.2 InnoCare Business Overview
  16. 7.3.3 InnoCare TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 InnoCare TYK2 Targeting Drugs Product Portfolio
  18. 7.3.5 InnoCare Recent Developments
  19. 7.4 Guangzhou Zaiji Pharmaceutical
  20. 7.4.1 Guangzhou Zaiji Pharmaceutical Company Information
  21. 7.4.2 Guangzhou Zaiji Pharmaceutical Business Overview
  22. 7.4.3 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product Portfolio
  24. 7.4.5 Guangzhou Zaiji Pharmaceutical Recent Developments
  25. 7.5 Changzhou Hengbang Pharmaceutical
  26. 7.5.1 Changzhou Hengbang Pharmaceutical Company Information
  27. 7.5.2 Changzhou Hengbang Pharmaceutical Business Overview
  28. 7.5.3 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product Portfolio
  30. 7.5.5 Changzhou Hengbang Pharmaceutical Recent Developments
  31. 7.6 BeiGene
  32. 7.6.1 BeiGene Company Information
  33. 7.6.2 BeiGene Business Overview
  34. 7.6.3 BeiGene TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 BeiGene TYK2 Targeting Drugs Product Portfolio
  36. 7.6.5 BeiGene Recent Developments
  37. 7.7 Ventyx Biosciences
  38. 7.7.1 Ventyx Biosciences Company Information
  39. 7.7.2 Ventyx Biosciences Business Overview
  40. 7.7.3 Ventyx Biosciences TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ventyx Biosciences TYK2 Targeting Drugs Product Portfolio
  42. 7.7.5 Ventyx Biosciences Recent Developments
  43. 7.8 Takeda (Nimbus Therapeutics)
  44. 7.8.1 Takeda (Nimbus Therapeutics) Company Information
  45. 7.8.2 Takeda (Nimbus Therapeutics) Business Overview
  46. 7.8.3 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product Portfolio
  48. 7.8.5 Takeda (Nimbus Therapeutics) Recent Developments
  49. 7.9 Sareum Holdings Pic
  50. 7.9.1 Sareum Holdings Pic Company Information
  51. 7.9.2 Sareum Holdings Pic Business Overview
  52. 7.9.3 Sareum Holdings Pic TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sareum Holdings Pic TYK2 Targeting Drugs Product Portfolio
  54. 7.9.5 Sareum Holdings Pic Recent Developments
  55. 7.10 Oncostellae
  56. 7.10.1 Oncostellae Company Information
  57. 7.10.2 Oncostellae Business Overview
  58. 7.10.3 Oncostellae TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Oncostellae TYK2 Targeting Drugs Product Portfolio
  60. 7.10.5 Oncostellae Recent Developments
  61. 7.11 Galapagos NV
  62. 7.11.1 Galapagos NV Company Information
  63. 7.11.2 Galapagos NV Business Overview
  64. 7.11.3 Galapagos NV TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Galapagos NV TYK2 Targeting Drugs Product Portfolio
  66. 7.11.5 Galapagos NV Recent Developments
  67. 7.12 Bristol Myers Squibb
  68. 7.12.1 Bristol Myers Squibb Company Information
  69. 7.12.2 Bristol Myers Squibb Business Overview
  70. 7.12.3 Bristol Myers Squibb TYK2 Targeting Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Bristol Myers Squibb TYK2 Targeting Drugs Product Portfolio
  72. 7.12.5 Bristol Myers Squibb Recent Developments
8 North America
  1. 8.1 North America TYK2 Targeting Drugs Market Size by Type
  2. 8.1.1 North America TYK2 Targeting Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America TYK2 Targeting Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America TYK2 Targeting Drugs Price by Type (2021-2032)
  5. 8.2 North America TYK2 Targeting Drugs Market Size by Application
  6. 8.2.1 North America TYK2 Targeting Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America TYK2 Targeting Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America TYK2 Targeting Drugs Price by Application (2021-2032)
  9. 8.3 North America TYK2 Targeting Drugs Market Size by Country
  10. 8.3.1 North America TYK2 Targeting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America TYK2 Targeting Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America TYK2 Targeting Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe TYK2 Targeting Drugs Market Size by Type
  2. 9.1.1 Europe TYK2 Targeting Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe TYK2 Targeting Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe TYK2 Targeting Drugs Price by Type (2021-2032)
  5. 9.2 Europe TYK2 Targeting Drugs Market Size by Application
  6. 9.2.1 Europe TYK2 Targeting Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe TYK2 Targeting Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe TYK2 Targeting Drugs Price by Application (2021-2032)
  9. 9.3 Europe TYK2 Targeting Drugs Market Size by Country
  10. 9.3.1 Europe TYK2 Targeting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe TYK2 Targeting Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe TYK2 Targeting Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China TYK2 Targeting Drugs Market Size by Type
  2. 10.1.1 China TYK2 Targeting Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China TYK2 Targeting Drugs Sales by Type (2021-2032)
  4. 10.1.3 China TYK2 Targeting Drugs Price by Type (2021-2032)
  5. 10.2 China TYK2 Targeting Drugs Market Size by Application
  6. 10.2.1 China TYK2 Targeting Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China TYK2 Targeting Drugs Sales by Application (2021-2032)
  8. 10.2.3 China TYK2 Targeting Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia TYK2 Targeting Drugs Market Size by Type
  2. 11.1.1 Asia TYK2 Targeting Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia TYK2 Targeting Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia TYK2 Targeting Drugs Price by Type (2021-2032)
  5. 11.2 Asia TYK2 Targeting Drugs Market Size by Application
  6. 11.2.1 Asia TYK2 Targeting Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia TYK2 Targeting Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia TYK2 Targeting Drugs Price by Application (2021-2032)
  9. 11.3 Asia TYK2 Targeting Drugs Market Size by Country
  10. 11.3.1 Asia TYK2 Targeting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia TYK2 Targeting Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia TYK2 Targeting Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA TYK2 Targeting Drugs Market Size by Type
  2. 12.1.1 SAMEA TYK2 Targeting Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA TYK2 Targeting Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA TYK2 Targeting Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA TYK2 Targeting Drugs Market Size by Application
  6. 12.2.1 SAMEA TYK2 Targeting Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA TYK2 Targeting Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA TYK2 Targeting Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA TYK2 Targeting Drugs Market Size by Country
  10. 12.3.1 SAMEA TYK2 Targeting Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA TYK2 Targeting Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA TYK2 Targeting Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 TYK2 Targeting Drugs Value Chain Analysis
  2. 13.1.1 TYK2 Targeting Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 TYK2 Targeting Drugs Production Mode & Process
  6. 13.2 TYK2 Targeting Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 TYK2 Targeting Drugs Distributors
  9. 13.2.3 TYK2 Targeting Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst